Filing Flows › Oscar Health (OSCR) › Q3 2026 › vs Q2 2026
Oscar Health (OSCR) Q3 2026 vs Q2 2026 (quarter over quarter)
Oscar Health's revenue rose $259M (+5%) from $4.9B in Q2 2026 to $5.1B in Q3 2026. Operating margin 3.5% against 8.0% (-4.5 pts).
Oscar Health, Q3 2026: revenue $5.1B (+72% year over year), operating margin 3.5%, net earnings $167M, operating cash flow −$1.2B. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Operating margin | 3.5% | 8.0% | -4.5 pts |
| Net margin | 3.3% | 7.4% | -4.2 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $5.1B | $4.9B | $259M | +5% |
| Operating profit | $178M | $389M | −$211M | -54% |
| Costs & expenses | $5.0B | $4.5B | $470M | +10% |
| Pre-tax earnings | $175M | $383M | −$208M | -54% |
| SG&A | $722M | $691M | $30.8M | +4% |
| Other operating costs | $4.2B | $3.8B | $439M | +12% |
| Net earnings | $167M | $362M | −$195M | -54% |
| Income tax | $8.1M | $21.2M | −$13.1M | -62% |
| Operating cash sources | $1.4B | −$1.7B | $3.1B | — |
| Depreciation & amortization | $6.5M | $6.0M | $512K | +8% |
| Share-based compensation | $22.3M | $20.7M | $1.6M | +8% |
| Cash used in operations | $1.2B | −$2.1B | $3.3B | — |
| Working capital & other | $1.4B | −$1.7B | $3.1B | — |
Questions
How much did Oscar Health's revenue grow quarter over quarter in Q3 2026?
Oscar Health's revenue rose $259M (+5%) from $4.9B in Q2 2026 to $5.1B in Q3 2026. Operating margin 3.5% against 8.0% (-4.5 pts).